Home ›
Trademark Categories ›
Pharmaceuticals ›
2015 ›
DU ›
DULIANZ
Trademark search for:
DULIANZ
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-07-08 — Application filed
2015-07-11 — Application filed
2015-07-13 — Application filed
2015-09-08 — Assigned to examiner
2015-09-09 — Suspension letter written
2015-09-09 — Letter of suspension e-mailed
2015-09-09 — Notification of letter of suspension e-mailed
2016-01-05 — Teas response to suspension inquiry received
2016-01-19 — Assigned to lie
2016-01-27 — Assigned to lie
2016-01-28 — Correspondence received in law office
2016-01-28 — Teas/email correspondence entered
2016-01-28 — Approved for pub - principal register
2016-02-05 — Law office publication review completed
2016-02-24 — Notification of notice of publication e-mailed
2016-03-15 — Published for opposition
2016-03-15 — Official gazette publication confirmation e-mailed
2016-05-31 — Registered-principal register
2017-01-31 — Correspondence received in law office
2017-04-05 — Review of correspondence complete - address updated
2019-12-10 — Correspondence received in law office
2020-01-08 — Review of correspondence complete - address updated
2021-05-31 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2022-12-16 — Cancelled sec. 8 (6-yr)
2022-12-16 — Final status recorded
Owner Information
Sanofi
75008 Paris FR
Sanofi
75008 Paris FR
Sanofi
75008 Paris FR
Correspondent
Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C. 151 WEST 42nd St., 17 Fl. NEW YORK, NY 10036 UNITED STATES
Filing Details
Filing Date:
2015-07-08
Status Date:
2022-12-16
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.